These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Delirium and stereotypy from anticholinergic antiparkinson drugs. Kulik AV; Wilbur R Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(1):75-82. PubMed ID: 7202232 [TBL] [Abstract][Full Text] [Related]
3. Anticholinergic toxicity masquerading as neuroleptic malignant syndrome: a case report and review. Catterson ML; Martin RL Ann Clin Psychiatry; 1994 Dec; 6(4):267-9. PubMed ID: 7647837 [TBL] [Abstract][Full Text] [Related]
4. Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. Granacher RP; Baldessarini RJ Arch Gen Psychiatry; 1975 Mar; 32(3):375-80. PubMed ID: 1115577 [TBL] [Abstract][Full Text] [Related]
5. Combined neuroleptic malignant syndrome and the central anticholinergic syndrome. Bennett DA J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):711. PubMed ID: 2213055 [No Abstract] [Full Text] [Related]
6. Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises. Sachdev P; Tang WM Aust N Z J Psychiatry; 1992 Dec; 26(4):666-70. PubMed ID: 1362053 [TBL] [Abstract][Full Text] [Related]
7. Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine. Hvizdos AJ; Bennett JA; Wells BG; Rappaport KB; Mendel SA Clin Pharm; 1983; 2(2):174-8. PubMed ID: 6883947 [No Abstract] [Full Text] [Related]
8. The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial. Goff DC; Arana GW; Greenblatt DJ; Dupont R; Ornsteen M; Harmatz JS; Shader RI J Clin Psychopharmacol; 1991 Apr; 11(2):106-12. PubMed ID: 2056136 [TBL] [Abstract][Full Text] [Related]
11. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study. Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239 [TBL] [Abstract][Full Text] [Related]
12. Oral candidiasis secondary to adverse anticholinergic effects of psychotropic medications. Stevens HE J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):145-6. PubMed ID: 17343565 [No Abstract] [Full Text] [Related]
13. Treatment of anticholinergic-induced ileus with neostigmine. Isbister GK; Oakley P; Whyte I; Dawson A Ann Emerg Med; 2001 Dec; 38(6):689-93. PubMed ID: 11719751 [TBL] [Abstract][Full Text] [Related]
14. [Quetiapine and anticholinergic drugs induced ischaemic colitis: A case study]. Cuny P; Houot M; Ginisty S; Horowicz S; Plassart F; Mentec H; Eftekhari P Encephale; 2017 Feb; 43(1):81-84. PubMed ID: 27637870 [TBL] [Abstract][Full Text] [Related]
15. Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine. Apiquian R; Fresán A; Herrera K; Ulloa RE; Lóyzaga C; de la Fuente-Sandoval C; Gutiérrez D; Nicolini H Int J Neuropsychopharmacol; 2003 Dec; 6(4):403-8. PubMed ID: 14604455 [TBL] [Abstract][Full Text] [Related]
16. Choreiform movements induced by anticholinergic therapy. West RR; Newgreen DB Med J Aust; 1979 Jul; 2(2):87-8. PubMed ID: 492035 [No Abstract] [Full Text] [Related]
17. Haloperidol and benztropine in rapid neuroleptization. Evans L Med J Aust; 1978 May; 1(10):567-8. PubMed ID: 683069 [No Abstract] [Full Text] [Related]
18. Anticholinergics: theoretical and clinical overview. Nishtala PS; Salahudeen MS; Hilmer SN Expert Opin Drug Saf; 2016 Jun; 15(6):753-68. PubMed ID: 26966981 [TBL] [Abstract][Full Text] [Related]
19. Anticholinergic Medication Burden in Pediatric Prolonged Critical Illness: A Potentially Modifiable Risk Factor for Delirium. Madden K; Hussain K; Tasker RC Pediatr Crit Care Med; 2018 Oct; 19(10):917-924. PubMed ID: 30284995 [TBL] [Abstract][Full Text] [Related]